A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2011
10/12/2011	CN102212539A Efficiently expressed series porcine alpha and gamma interferon genes and application of expressed protein thereof
10/12/2011	CN102212531A Preparation method and application of recombinant Cladosporium herbarum allergen Cla h8 protein
10/12/2011	CN102212527A Porcine alpha-interferon gene with efficient expression and high antiviral activity and application of expression protein thereof
10/12/2011	CN102212512A Pegylated staphylokinase mutant, and preparation method and application thereof
10/12/2011	CN102212140A Preparation of VEGF165 (vascular endothelial growth factor 165) analogue
10/12/2011	CN102212127A Glucagon-like peptide-2 poly(ethylene glycol) conjugate, and preparation method and application thereof
10/12/2011	CN102212126A Recombinant EDI (Endothelial Genesis Inhibitor)-8t protein with endothelial cell growth inhibiting activity
10/12/2011	CN102212125A Recombinant lamprey lysin as well as preparation method and application thereof in preparing antithrombotic medicament
10/12/2011	CN102212124A Scylla paramamosain anti-lipopolysaccharide factor, and preparation method and application thereof
10/12/2011	CN102212119A Polypeptide with antibacterial activity and application thereof
10/12/2011	CN102212118A Antibacterial peptide B and application thereof
10/12/2011	CN102212117A Antibacterial peptide A and application thereof
10/12/2011	CN102212115A Newly found hepatitis C virus epitope
10/12/2011	CN102212114A New hepatitis C virus epitope
10/12/2011	CN102212110A Beta-lactamase inhibitory peptide and application thereof
10/12/2011	CN102212109A Bone polypeptide compound separated from ossotide injection and application thereof
10/12/2011	CN102212019A Branched water-soluble polymers and their conjugates
10/12/2011	CN102210872A Polyethylene glycol modified peptide pharmaceutical formulation and preparation method thereof
10/12/2011	CN102210864A Formula of medicament for treating non-infectious ocular inflammations, and inhibiting corneal neovascularization and anti-rejection reaction generated after corneal grafting
10/12/2011	CN102210856A Collagen eye drops and preparation method thereof
10/12/2011	CN102210855A Complex of marine oligosaccharides and collagen peptides, preparation method thereof and application thereof
10/12/2011	CN102210854A Method for carrying out virus inactivation on pig fibrinogens through freeze-drying and heating
10/12/2011	CN102210853A Method for preparing liposome containing EGFs (Epidermal Growth Factors) and transdermal short peptide fusion proteins, for controlling diabetic foot gangrene
10/12/2011	CN102210852A Treatment of T-cell mediated diseases
10/12/2011	CN102210851A Application of human alpha b crystalline protein in preparing medicament for protecting retinal ganglion cells
10/12/2011	CN102210850A Method for increasing expression of deacetylase
10/12/2011	CN102210849A Preparation of cyclosporine A nano-particle eye drop
10/12/2011	CN102210783A Composition preparation of donkey-hide glue, and preparation method thereof
10/12/2011	CN102210703A Dextran of polypeptide donkey-hide gelatin
10/12/2011	CN102210668A Application of cantharidin and derivants thereof in preparation of tumor chemotherapy sensitivity enhancing medicine
10/12/2011	CN102210639A Plant collagen essence
10/12/2011	CN102210630A System and method for preparing nosiheptide premix particles
10/12/2011	CN101947213B Method for preparing microcapsules from peptidoglycan in lactic acid bacterial cell walls
10/12/2011	CN101569608B Oral solid lipid nano-particle preparation of calcitonin and preparation method thereof
10/12/2011	CN101466392B Pharmaceutical composition for preventing or curing HIV infection and use thereof
10/12/2011	CN101433713B GnRH-PE mutant fusion protein and uses thereof
10/12/2011	CN101212982B FK228 derivates as HDAC inhibitors
10/12/2011	CN101181370B Medicine for treating colitis
10/12/2011	CN101160139B Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing PEDF and FGF2
10/11/2011	US8034959 Methods of treating cancer with an antibody-drug conjugate
10/11/2011	US8034901 Bcl-G polypeptides, encoding nucleic acids and methods of use
10/11/2011	US8034900 Water-soluble thioester and selenoester compounds and methods for making and using the same
10/11/2011	US8034899 HIV fusion inhibitor peptides with improved biological properties
10/11/2011	US8034897 Recombinant spider silk proteins
10/11/2011	US8034790 Use of MDA-7 to inhibit pathogenic infectious organisms
10/11/2011	US8034787 Enzyme-cleavable prodrug compounds
10/11/2011	US8034786 Methods and means for controlling the endocytosis and subsequent degradation of growth hormone receptor
10/11/2011	US8034785 Adsorbent adsorbing antibody against β1 adrenoreceptor
10/11/2011	US8034784 Method of suppressing or reducing IL-TIF-induced inflammation, or treating associated conditions thereof, using Zcytor16
10/11/2011	US8034783 Prodomain modulators of ADAM 10
10/11/2011	US8034782 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
10/11/2011	US8034781 Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth
10/11/2011	US8034780 Isolation, purification, and structure elucidation of the antiproliferative compound coibamide A
10/11/2011	US8034779 Inhibitors of BCL-2
10/11/2011	US8034778 Neuroprotective compounds and uses thereof
10/11/2011	US8034777 Modified anticholinergic neurotoxins as modulators of the autoimmune reaction
10/11/2011	US8034776 Orallyl administering a zonulin antagonist comprising an octapeptide; monitoring; administering a gluten challenge; diagnosis of celiac disease by determining amount of interferons, interleukins, or nitrates in a sample and evaluating
10/11/2011	US8034775 Kallikrein-inhibitor therapies
10/11/2011	US8034774 Compositions and methods for counteracting effects of reactive oxygen species and free radicals
10/11/2011	US8034773 Immunostimulatory compositions and uses thereof
10/11/2011	US8034772 Inhibitor of vascular endothelial cell growth factor
10/11/2011	US8034771 IL-1F6 polypeptides
10/11/2011	US8034770 FGF21 polypeptides comprising two or more mutations
10/11/2011	US8034769 Oxidized proteins and oxidized protein inhibitor compositions and methods of use thereof
10/11/2011	US8034768 Composition and method for the treatment of diseases affected by histone deacetylase inhibitors
10/11/2011	US8034767 Method for producing purine nucleosides and nucleotides by fermentation using a bacterium belonging to the genus Escherichia or Bacillus
10/11/2011	US8034765 Compositions and methods for preparation of poorly water soluble drugs with increased stability
10/11/2011	US8034764 Modulation of SOCS expression in therapeutic regimens
10/11/2011	US8034763 Platelet aggregation inhibitor composition
10/11/2011	US8034762 Treatment of subarachnoid hemorrhage with Apo E analogs
10/11/2011	US8034607 Methods of enhanced heterologous protein secretion
10/11/2011	US8034561 HIN-1, a tumor suppressor gene
10/11/2011	US8034556 Regulation of glucose and insulin levels by GnT-4 glycosyltransferase activity
10/11/2011	US8034385 Anti-ageing skin cosmetic
10/11/2011	US8034384 Method of increasing biocompatibility of medical device by generating nitric oxide
10/11/2011	US8034378 water; a biodegradable microparticle of a polylactone, polyorthoester, a polyanhydride, or a polycyanoacrylate; an antigen adsorbed to the microparticle; and a phospholipid adjuvant with one or more phosphoric acid or phosphodiester groups and linear alkane groups
10/11/2011	US8034375 Combinations and modes of administration of therapeutic agents and combination therapy
10/11/2011	US8034360 Use of human prostate cell lines in cancer treatment
10/11/2011	US8034358 Surface antigen
10/11/2011	US8034357 Treatment of fine wrinkles with clostridia neurotoxins
10/11/2011	US8034352 Tetrameric cytokines with improved biological activity
10/11/2011	US8034350 Methylated tat polypeptides and methods of use thereof
10/11/2011	US8034348 Prevention and treatment of amyloidogenic disease
10/11/2011	US8034347 Method for inhibiting apoptosis through the p75 neurotrophin receptor
10/11/2011	US8034343 Methods of treating inflammatory disorders of the lungs
10/11/2011	US8034341 Methods of inhibiting tumor growth using blocking antibodies to IL-23R
10/11/2011	US8034339 administering an antibody that specifically binds to the amyloid deposit or a component thereof; can be a human, humanized, chimeric or nonhuman antibody and can be monoclonal or polyclonal; also a novel monoclonal antibody which specifically binds to an epitope within residues 13-28 of A beta
10/11/2011	US8034336 Antibodies against a peptide epitope of apoliprotein B
10/11/2011	US8034334 Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy
10/11/2011	US8034327 Hyperglycosylated IL-7, preparation and uses
10/11/2011	US8034326 IL-21 variants
10/11/2011	CA2489239C Botulinum toxins for treating priapism
10/11/2011	CA2483000C Oral care compositions containing ovomucin
10/11/2011	CA2468258C Peptide agonists of prostate-specific antigen, and uses therefor
10/11/2011	CA2457840C Hdl for the treatment of stroke and other ischemic conditions
10/11/2011	CA2442993C Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/11/2011	CA2438116C Amphoteric liposomes and the use thereof
10/11/2011	CA2438094C Increased recovery of active proteins
10/11/2011	CA2420537C A composition for treatment of parkinson's disease
10/11/2011	CA2416475C Medicinal uses of mu-opioid receptor agonists

1 ... 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 ... 3163